These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2756678)

  • 1. [A mathematical model for predicting the efficacy of glucocorticoid therapy of glomerulonephritis].
    Bagdasarova IV; Ivanov DD
    Vrach Delo; 1989 Apr; (4):26-9. PubMed ID: 2756678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetically determined variability in cell glucocorticoid receptors as a factor in sensitivity to glucocorticoid therapy in the nephrotic syndrome].
    Liashko VN; Grinberg KN; Mukhin NA; Dziuba MT
    Vestn Akad Med Nauk SSSR; 1980; (6):28-32. PubMed ID: 7405376
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of morphological types of nephrotic glomerulonephritis and the number of glucocorticoid receptors of lymphocytes for prognosis of the effectiveness of glucocorticoid therapy].
    Sasu BI; Mukhin NA; Serov VV; Varshavskiĭ VA
    Arkh Patol; 1984; 46(6):21-6. PubMed ID: 6383286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Determination of the sensitivity to glucocorticoids in vitro].
    Mil'ko VI; Taradiĭ NN; Bagdasarova IV; Moskalenko NI; Ivanov DD
    Lab Delo; 1989; (2):27-8. PubMed ID: 2467052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glucocorticoids in the treatment of patients with glomerulonephritis and the nephrotic syndrome].
    Kolesnyk MO; Lapchyns'ka II
    Lik Sprava; 1993 Sep; (9):23-8. PubMed ID: 8085341
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of the amount of somatic cell glucocorticoid receptors as one of the prospective approaches to the individual prognosis of glucocorticosteroid therapy].
    Mukhin NA; Liashko VN; Grinberg KN
    Ter Arkh; 1987; 59(5):69-73. PubMed ID: 3616948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The morphofunctional characteristics of the blood lymphocytes in steroid-sensitive and steroid-resistant glomerulonephritis].
    Bagdasarova IV; Ivanov DD; Afanas'eva VV
    Arkh Patol; 1991; 53(5):28-32. PubMed ID: 1883272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The immunodeficiency state and the efficacy of the glucocorticoid therapy of patients with glomerulonephritis and the nephrotic syndrome].
    Kolesnyk MO; Dorets'kyĭ VV
    Lik Sprava; 1992; (11-12):53-5. PubMed ID: 1292222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic drug therapy in steroid-resistant glomerulonephritis.
    White RH
    Proc R Soc Med; 1967 Nov; 60(11 Part 1):1164-8. PubMed ID: 6060717
    [No Abstract]   [Full Text] [Related]  

  • 10. [The efficacy of the glucocorticoid and cytostatic therapy of lupus glomerulonephritis].
    Diadyk AI; Vasilenko IV; Siniachenko OV; Iarovaia NF; Shpilevaia NI; Bagriĭ AE; Khomenko MV; Chernykh OS; Efremenko VA; Zviagina TV
    Ter Arkh; 1992; 64(10):111-4. PubMed ID: 1485238
    [No Abstract]   [Full Text] [Related]  

  • 11. [Urinary RBP and glucocorticoid hormone therapy sensibility in adult primary nephrotic syndrome].
    Chen X; Cheng MC; Duan SB; Xia YC
    Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):175-7. PubMed ID: 12536664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid receptors and steroid sensitivity in normal and neoplastic human lymphoid tissues: a review.
    Homo-Delarche F
    Cancer Res; 1984 Feb; 44(2):431-7. PubMed ID: 6362849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoids in renal disease. Theoretical basis, consequences and efficacy of use in the pediatric patient.
    Friedman AL; Chesney RW
    Am J Nephrol; 1982; 2(6):330-41. PubMed ID: 6762095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amino acid metabolism in steroid therapy of nephropathies].
    Pyrig LA; Nikula TD
    Vrach Delo; 1969 Feb; 2():135-7. PubMed ID: 5779366
    [No Abstract]   [Full Text] [Related]  

  • 15. [A clinico-morphological analysis of the efficacy of therapy in chronic glomerulonephritis using prednisone, a cytostatic, an anticoagulant and an antiaggregant].
    Ratner MIa; Fedorova ND
    Urol Nefrol (Mosk); 1996; (2):32-5. PubMed ID: 8677550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinico-laboratory pattern and effectiveness of glucocorticoid therapy of patients with primary diffuse mesangioproliferative glomerulonephritis].
    Diadyk AI; Dikshteĭn EA; Vasilenko IV; Siniachenko OV; Kobets VG
    Ter Arkh; 1987; 59(8):35-7. PubMed ID: 3686443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P; Frey FJ
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-inflammatory activity of glucocorticoids in nephrology].
    Nykula TD; Bondur VV; Moĭseienko VO; Aleksieieva NH
    Lik Sprava; 2013; (5):94-8. PubMed ID: 24605641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glucocorticoid receptors and predicting the efficacy of glucocorticoid therapy of nephritis].
    Sasu BI; Mukhin NA; Liashko VN; Freĭdin MI
    Klin Med (Mosk); 1984 Apr; 62(4):75-9. PubMed ID: 6737971
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical and pathologic correlations in infantile nephrotic syndrome].
    Gaboardi F; Chiccoli C
    Minerva Pediatr; 1971 Mar; 23(13):569-75. PubMed ID: 5576857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.